THE VAGINAL MICROBIOME, MATERNAL RESPONSE, AND PRETERM BIRTH
阴道微生物群、孕产妇反应和早产
基本信息
- 批准号:10471265
- 负责人:
- 金额:$ 61.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-12 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:37 weeks gestationAnti-Inflammatory AgentsBacteriaBacterial GenesBase SequenceBiologicalBiologyChickenpoxClinicalClinical DataCommunitiesDataDecision TreesDevelopmentDiseaseDistantEnvironmentEpidemiologistFamilyFutureGene ExpressionGenomeGenomicsGoalsHealth Care CostsHuman PapillomavirusImmune responseInfantInfectionInflammationInflammatoryInflammatory ResponseInfluenzaInformaticsInstitutesInvestigationJointsKnowledgeLeadLifeLightLinkMalignant neoplasm of cervix uteriMeasurableMetagenomicsMicrobeMorbidity - disease rateNeonatal MortalityOutcomePathway interactionsPatientsPhysiologicalPregnancyPregnancy ComplicationsPregnant WomenPremature BirthPreventionPrevention MeasuresPrevention strategyProductionPublic HealthResearchResearch DesignResearch InfrastructureRibosomal RNARiskSamplingScreening procedureShotgun SequencingSignal TransductionStructureSurvivorsTechnologyTerm BirthTestingTimeUnited StatesUniversitiesVaginaViralVirusVirus DiseasesWashingtonWomanbacterial communitybacteriomeclinical applicationcohortcostcytokinedata infrastructuredesigngenome sequencinghigh riskimprovedinnovationmicrobial communitymicrobial genomicsmicrobial hostmicrobiomemortality riskneonatal morbiditynovelpatient populationpredictive signaturepreventracial diversityresponsevaginal microbiomevirome
项目摘要
ABSTRACT
An estimated 13 million preterm births (PTBs) occur annually worldwide, and PTB is the single most
significant contributing factor to neonatal morbidity and mortality. Mechanisms underlying preterm
birth are unknown hampering development of effective prediction and prevention strategies. PTB is
linked to local and distant infections and recent data suggests that vaginal bacterial microbiome early
in pregnancy is associated with subsequent preterm birth. Viral infections behave differently during
pregnancy, with common viral infections such as varicella and influenza causing much more severe
disease during pregnancy and human papillomavirus, the causative virus in cervical cancer,
associated with a 2-fold increased risk for PTB. However, comprehensive assessment of vaginal viral
communities during pregnancy has not been performed. Lastly, although maternal inflammation is
one of the leading triggers for PTB the precise constellation of inflammatory signals is not known. We
propose that examining microbial communities or host response alone is incomplete, but that their
combination will lead to refined definitions of appropriate and inappropriate microbe-maternal biology
and shed new light on the old problem of PTB.
Our central hypothesis is that preterm birth can be estimated by a combination of three criteria:
vaginal bacterial communities, vaginal eukaryotic viral communities, and maternal
inflammatory response. We have an interdisciplinary team assembled including perinatologists,
epidemiologists, virologists, and genomics informatics experts, leveraging the unique capabilities of
the McDonnell Genome Institute at Washington University in St. Louis, a well-established pregnancy
bio-specimen and clinical data infrastructure, and a high-PTB burdened racially diverse patient
population to test this novel hypothesis.
The aims of this project are: 1) Determine the ability of bacterial and viral communities in the vagina
and their dynamics over time to predict preterm birth 2) Determine the ability of the host inflammatory
response in the vagina in the context of microbial communities to predict preterm birth. The proposed
research is innovative, for the first time, comprehensively characterizing the eukaryotic vaginal virome
simultaneously with vaginal bacterial communities and longitudinally capturing the maternal response
to these communities. We employ an efficient study design, a well-established research
infrastructure, and renowned genome sequencing expertise to test a physiologically plausible but
uninvestigated paradigm that bacterial and viral communities in concert with the maternal host
response can predict PTB.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Molly Stout其他文献
Molly Stout的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Molly Stout', 18)}}的其他基金
Fully Quantitative Cervical Elastography for Prediction of Preterm Birth in Nulliparous Patients
全定量宫颈弹性成像预测未产妇早产
- 批准号:
10657884 - 财政年份:2023
- 资助金额:
$ 61.5万 - 项目类别:
THE VAGINAL MICROBIOME, MATERNAL RESPONSE, AND PRETERM BIRTH
阴道微生物组、孕产妇反应和早产
- 批准号:
9578621 - 财政年份:2018
- 资助金额:
$ 61.5万 - 项目类别:
THE VAGINAL MICROBIOME, MATERNAL RESPONSE, AND PRETERM BIRTH
阴道微生物群、孕产妇反应和早产
- 批准号:
10242865 - 财政年份:2018
- 资助金额:
$ 61.5万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 61.5万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 61.5万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 61.5万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 61.5万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 61.5万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 61.5万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 61.5万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 61.5万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 61.5万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 61.5万 - 项目类别: